Can particle beam therapy be improved using helium ions? – a planning study focusing on pediatric patients

Abstract Aim To explore the potential of scanned helium ion beam therapy (4He) compared to proton therapy in a comparative planning study focusing on pediatric patients. This was motivated by the superior biological and physical characteristics of 4He. Material and methods For eleven neuroblastoma (NB), nine Hodgkin lymphoma (HL), five Wilms tumor (WT), five ependymoma (EP) and four Ewing sarcoma (EW) patients, treatment plans were created for protons and 4He. Dose prescription to the planning target volume (PTV) was 21 Gy [relative biological effectiveness (RBE)] (NB), 19.8 Gy (RBE) (HL), 25.2 Gy (RBE) for the WT boost volume and 54 Gy (RBE) for EP and EW patients. A pencil beam algorithm for protons (constant RBE = 1.1) and 4He was implemented in the treatment planning system Hyperion. For 4He the relative biological effectiveness (RBE) was calculated with a ‘zonal’ model based on different linear energy transfer regions. Results Target constraints were fulfilled for all indications. For NB patients differences for kidneys and liver were observed for all dose-volume areas, except the high-dose volume. The body volume receiving up to 12.6 Gy (RBE) was reduced by up to 10% with 4He. For WT patients the mean and high-dose volume for the liver was improved when using 4He. For EP normal tissue dose was reduced using 4He with 12.7% of the voxels receiving higher doses using protons. For HL and EW sarcoma patients the combination of large PTV volumes with the position of the organs at risk (OARs) obliterated the differences between the two particle species, while patients with the heart close to the PTV could benefit from 4He. Conclusion Treatment plan quality improved with 4He compared to proton plans, but advantages in OAR sparing were depending on indication and tumor geometries. These first results of scanned 4He therapy motivate comprehensive research on 4He, including acquisition of experimental data to improve modeling of 4He.

[1]  Zuofeng Li,et al.  Proton therapy in a pediatric patient with stage III Hodgkin lymphoma , 2013, Acta oncologica.

[2]  Tatsuaki Kanai,et al.  Microdosimetric Measurements and Estimation of Human Cell Survival for Heavy-Ion Beams , 2006, Radiation research.

[3]  B. S. Sørensen,et al.  LET-painting increases tumour control probability in hypoxic tumours , 2014, Acta oncologica.

[4]  R. Pötter,et al.  Can treatment of pediatric Hodgkin’s lymphoma be improved by PET imaging and proton therapy? , 2012, Strahlentherapie und Onkologie.

[5]  A. Brahme,et al.  Depth absorbed dose and LET distributions of therapeutic 1H, 4He, 7Li, and 12C beams. , 2007, Medical physics.

[6]  J. Lyman,et al.  MEASUREMENT OF OXYGEN EFFECT AND BIOLOGICAL EFFECTIVENESS OF A 910-MeV HELIUM ION BEAM USING CULTURED CELLS (T1). , 1970 .

[7]  I. Kaplan,et al.  Helium charged particle radiotherapy for meningioma: experience at UCLBL. University of California Lawrence Berkeley Laboratory. , 1994, International Journal of Radiation Oncology, Biology, Physics.

[8]  I. Paddick,et al.  A simple scoring ratio to index the conformity of radiosurgical treatment plans , 2001 .

[9]  T. Haberer,et al.  Test bench to commission a third ion source beam line and a newly designed extraction system. , 2012, The Review of scientific instruments.

[10]  Anders Brahme,et al.  Recent advances in light ion radiation therapy. , 2004, International Journal of Radiation Oncology, Biology, Physics.

[11]  Zuofeng Li,et al.  Prescribing, Recording, and Reporting Proton-Beam Therapy , 2009 .

[12]  Hermann Fuchs,et al.  Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion. , 2015, Medical physics.

[13]  R. Pötter,et al.  Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. , 2015, The Lancet. Oncology.

[14]  D. Georg,et al.  A pencil beam algorithm for helium ion beam therapy. , 2012, Medical physics.

[15]  A Loasses,et al.  Particle beam therapy (hadrontherapy): basis for interest and clinical experience. , 1998, European journal of cancer.

[16]  M. Aznar,et al.  The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma , 2013, Acta oncologica.

[17]  Cornelius A. Tobias,et al.  Heavy-Ion Radiobiology: Cellular Studies , 1984 .

[18]  H. Tsujii,et al.  ICRU Report No. 78, Prescribing, recording, and reporting proton-beam therapy. , 2007 .

[19]  M. Raju.  A heavy particle comparative study Part III : OER and RBE , 1979 .

[20]  J. Kruse,et al.  Optimizing normal tissue sparing in ion therapy using calculated isoeffective dose for ion selection. , 2012, International journal of radiation oncology, biology, physics.

[21]  D. Georg,et al.  Comparison of basic features of proton and helium ion pencil beams in water using GATE. , 2012, Zeitschrift fur medizinische Physik.

[22]  M. Durante,et al.  Particle species dependence of cell survival RBE: Evident and not negligible , 2013, Acta oncologica.

[23]  I. Paddick.  A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. , 2000, Journal of neurosurgery.

[24]  D. Char,et al.  Ten-year follow-up of helium ion therapy for uveal melanoma. , 1998, American journal of ophthalmology.

[25]  J. Hannigan,et al.  Comparison of helium-ion radiation therapy and split-course megavoltage irradiation for unresectable adenocarcinoma of the pancreas. Final report of a Northern California Oncology Group randomized prospective clinical trial. , 1988, Radiology.

[26]  T. Björk-Eriksson,et al.  Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study , 2005, Acta oncologica.